1. Targeted Therapy–based Combination Treatment in Rhabdomyosarcoma
   Anke E.M. van Erp et al, 2018, Molecular Cancer Therapeutics CrossRef
2. Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
   Margaretha Skowron et al, 2018, International Journal of Molecular Sciences CrossRef
3. Discovery of novel candidates for anti-liposarcoma therapies by medium-scale high-throughput drug screening
   Iwona Grad et al, 2021, PLOS ONE CrossRef
4. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers
   Clara Savary et al, 2023, Cell Reports Medicine CrossRef
5. Inhibitors of apoptosis: clinical implications in cancer
   Mervat S. Mohamed et al, 2017, Apoptosis CrossRef
6. Surgical Management in Pediatric Malignant Solid Tumors
   Shuichiro Uehara, 2018, Journal of Nihon University Medical Association CrossRef
7. A five‐gene signature may predict sunitinib sensitivity and serve as prognostic biomarkers for renal cell carcinoma
   Yuan‐Lei Chen et al, 2018, Journal of Cellular Physiology CrossRef
8. Polo-like Kinase 4: A Multifaceted Marker Linking Tumor Aggressiveness and Unfavorable Prognosis, and Insights into Therapeutic Strategies
   Youngtaek Kim et al, 2023, Cancers CrossRef
9. Rapamycin enhances the anti-angiogenesis and anti-proliferation ability of YM155 in oral squamous cell carcinoma
   Kong-Liang Li et al, 2017, Tumor Biology CrossRef
10. Simultaneous Imaging and Visualizing the Association of Survivin mRNA and Telomerase in Living Cells by Using a Dual-Color Encoded DNA Nanomachine
    Chuan Zhao et al, 2023, Analytical Chemistry CrossRef
11. A fluorescent 3D cell culture assay for high throughput screening of cancer drugs down-regulating survivin
    Xin Xin et al, 2019, Journal of Biotechnology CrossRef
12. Non-Small-Cell Lung Cancer Regression by siRNA Delivered Through Exosomes That Display EGFR RNA Aptamer
    Zhefeng Li et al, 2021, Nucleic Acid Therapeutics CrossRef